Articles from: Molecular medicine most read (cell.com)
 |
|
|
| Next Page
| |
| Therapies for multiple sclerosis: translational achievements and outstandin (more) | 2013 04 26 |
|
| Mounting a strategic offense: fighting tumor vasculature with oncolytic vir (more) | 2013 04 26 |
|
|
|
| Notch signaling in pancreatic cancer: oncogene or tumor suppressor? (more) | 2013 04 26 |
|
|
| The BCL2 code to dopaminergic development and Parkinson's disease (more) | 2013 03 24 |
|
|
| Delivering RNAi therapeutics with non-viral technology: a promising strateg (more) | 2013 03 24 |
|
| cAMP responsive element modulator: a critical regulator of cytokine product (more) | 2013 03 14 |
|
| Mutation rate in stem cells: an underestimated barrier on the way to therap (more) | 2013 03 14 |
|
|
|
| Semaphorins 3A and 7A: potential immune and neuroregenerative targets in mu (more) | 2013 02 24 |
|
| Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch t (more) | 2013 02 02 |
|
|
| Shared dysregulated pathways lead to Parkinson's disease and diabetes (more) | 2013 02 02 |
|
|
| Estrogen synthesis and signaling pathways during aging: from periphery to b (more) | 2013 01 27 |
|
|
| CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem (more) | 2013 01 16 |
|
|
|
|
|
| mTOR: on target for novel therapeutic strategies in the nervous system (more) | 2012 12 22 |
|
| Exploring the effects of polymorphisms on cis-regulatory signal transductio (more) | 2012 12 22 |
|
| TRP channels: diagnostic markers and therapeutic targets for breast cancer? (more) | 2012 12 19 |
|
|
|
|
|
|
|
|
| Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis (more) | 2012 11 15 |
|
|
|
|
|
|
| Biospecimens, biomarkers, and burgeoning data: the imperative for more rigo (more) | 2012 11 07 |
|
|
|
| Sense from nonsense: therapies for premature stop codon diseases (more) | 2012 10 23 |
|
| Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppr (more) | 2012 10 23 |
|
|
|
| Mapping domains and mutations on the skeletal muscle ryanodine receptor cha (more) | 2012 10 16 |
|
|
| Next Page
| |